Cambridge Heart, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Cambridge Heart, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Cambridge Heart, Inc.. The Company's principal activity is to conduct research and develop and market products for the non-invasive diagnosis of cardiac disease. Its products incorporate its proprietary technology for the measurement of Microvolt T-Wave Alternans to non-invasively measure Microvolt levels of T-Wave Alternans in order to predict the risk of SCD.The Company's Heartwave System is used to perform a Microvolt T-Wave Alternans Test, a non-invasive measurement of subtle beat-to-beat fluctuation in a patient's heartbeat. Its CH 2000 performs conventional cardiac stress tests using the T-wave Alternans technology. All the products are cleared by the Federal Drug Administration for sale in the United States and have received the CE mark for sale in Europe. The Company sells its products primarily to cardiology group practices, hospitals and research institutions. It sells products in the United States, Europe and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report